Update: Safe handling of monoclonal antibodies in healthcare settings

Theme Cancer Pharmacists, Clinical Trials & Research Professionals
Resource Type Position Statement
DATE 10 March 2023

Update: Safe handling of monoclonal antibodies in healthcare settings

This position statement was published in the Asia Pacific Journal of Clinical Oncology, 10 March 2023, https://doi.org/10.1111/ajco.13943

The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with regards to handling monoclonal antibodies (mABs) in healthcare settings; and (b) update the recommendations in the Clinical Oncology Society of Australia (COSA) safe handling of monoclonal antibodies in healthcare settings position statement, published in 2013.

Practitioners should follow the 14 recommendations to lower occupational risk when handling mABs. Another Position Statement update should occur in 5–10 years to ensure the currency of recommendations.

DOWNLOAD

Join Australia's leading oncology community & make an impact

Become a COSA member

Twitter
@COSAoncology

COSAoncology 5 days ago

Thanks to the Australian Society of Medical Imaging and Radiation Therapy for renewing as a COSA Associated organisation. #ASMIRT members are invited to take advantage of discounted COSA membership: cosa.org.au/membership/mem…

COSAoncology 5 days ago

Thank you, @PathologyRCPA for continuing as a COSA Affiliated organisation. Did you know RCPA members can join or renew with COSA at a discounted rate? bit.ly/3s5mOC6

COSAoncology 6 days ago

The latest Cancer Pharmacists Group eNews in CPG members' inboxes and on the COSA website. Stay up to date and stay connected. bit.ly/3RhZY6Q

COSAoncology 13 days ago

The latest Exercise Group eNews is out now with a recap of exercise at Cancer Survivorship 2025, project updates, and member publications. Check your inbox or login to your COSA member account bit.ly/4cI0nc3 to subscribe. View it online anytime at bit.ly/3E8IOpf

COSAoncology 13 days ago

On inaugural World Psycho-Oncology Day #WPOD, COSA in partnership with PoCoG, is calling for nominations for the 2025 COSA Psycho-Oncology Awards. The winners will be presented at the 2025 joint COSA-IPOS meeting in Adelaide in November. More information bit.ly/4i9Avrg

COSAoncology 13 days ago

Today is World Psycho-Oncology Day an initiative of the International Psycho-Oncology Society (IPOS) to "elevate the visibility and impact of psycho-oncology worldwide." Haryana Dhillon briefly explains what psycho-oncology is and why it's important.

COSAoncology 14 days ago

Check your inbox for the latest Survivorship Group eNews. If you're not subscribed, login to your COSA member account bit.ly/4cI0nc3 and update your preferences. Members can view the eNews online anytime at bit.ly/3FW4BkF

COSAoncology 14 days ago

COSA supports all efforts to create a healthy workplace culture and environment that delivers best practice, patient-centred care for people with cancer.

COSAoncology 20 days ago

The COSA Annual Report 2024 is available now on our website. Read about progress being made towards our goal of quality multidisciplinary cancer care for all. With reports from the President, CEO, ASM Co-convenors, COSA Groups and Affiliated Organisations. bit.ly/3RBFxBH

COSAoncology 27 days ago

Our March member newsletter is out now. Check your inbox or log into your COSA account for the latest COSA news, member updates, journal articles and events. bit.ly/4j4unRT

Update: Safe handling of monoclonal antibodies in healthcare settings